Health

Hammond Care

First of its kind program embeds high-level dementia care expertise in Catholic Homes Perth

18-Jan-2019 10:00 AM
A new first of its kind program from HammondCare’s The Dementia Centre is improving quality of life for people with dementia by enabling a better informed and equipped aged care sector.

Business Wire Australia and New Zealand

Terns Pharmaceuticals Announces the Appointment of Erin Quirk, M.D., as Chief Medical Officer

18-Jan-2019 8:45 AM
SAN MATEO, Calif. & SHANGHAI--(BUSINESS WIRE)--Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly targeted, oral, small-molecule drugs to treat NASH and cancer, announced tod

University of Auckland

EMBARGOED UNTIL 2am FRIDAY 18 JANUARY 2019 NZT: Doctors, drugs of dependence and discipline: new review out

17-Jan-2019 2:40 PM
Only 24 doctors in 20 years have faced disciplinary action for inappropriate prescribing of drugs of dependence in Aotearoa New Zealand, a new review has revealed. The review’s lead author says the low number probably reflects that discipline is a last resort, which is fitting since drug dependence should be treated as a health issue rather than a crime.

University of Auckland

STRICTLY EMBARGOED UNTIL 11pm MONDAY 21 JANUARY 2019 (NZT) Are you a super pooper?

17-Jan-2019 8:34 AM
Fecal transplants could be used to treat intestinal disorders like inflammatory bowel disease – and perhaps even help prevent Alzheimer’s and cancer – if we can unlock the secrets of the gut-rejuvenating “super donor”, say researchers at the University of Auckland-based Liggins Institute.

Business Wire Australia and New Zealand

Pierre Fabre and its Partner Array BioPharma Announce 15.3 Months Median OS Observed from the Phase 3 BEACON CRC Safety Lead-in of BRAFTOVI®, MEKTOVI® and ERBITUX® in BRAF-Mutant Metastatic CRC

16-Jan-2019 9:34 AM
– Data will be presented at ASCO 2019 Gastrointestinal Cancers Symposium – – Updated confirmed ORR remains 48% and updated median PFS remains 8.0 months – Intended for international media only/not intended for UK- and US-based media

Hammond Care

Tips for ageing well in 2019

15-Jan-2019 1:41 PM
Ageing is inevitable, we can’t stop it or slow it down but we can aim to do it well.

Business Wire Australia and New Zealand

Henry Schein and Vets First Choice Announce Board of Directors for Covetrus

15-Jan-2019 9:48 AM
David E. Shaw to serve as Chairman of the Board; Philip Laskawy to serve as Lead Independent Director MELVILLE, N.Y. & PORTLAND, Maine--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) and Vets First Choice today announced th

Hammond Care

Call for doctors to join in better approach for dementia care

14-Jan-2019 4:52 PM
Leading Australian dementia care service providers have today highlighted concerns about the use of strong medications in dementia care – including the role of prescribing doctors – while also pointing to the benefits of relationship-based care.

Business Wire Australia and New Zealand

Gynesonics Announces Publication of Final SONATA IDE Pivotal Trial Results in the Journal, Obstetrics and Gynecology

11-Jan-2019 8:24 AM
Robust Outcomes Support the Potential of the Sonata System as a First-Line Treatment for Symptomatic Uterine Fibroids REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, a women’s healthcare company and the developer of the Sona

Business Wire Australia and New Zealand

R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide

11-Jan-2019 8:20 AM
  The new Code of Practice in place from 1 January 2019, imposes a complete ban on gifts and promotional aids Industry moves beyond compliance and reaffirms its commitment to ensuring an ethical framework as a way to increase i

Business Wire Australia and New Zealand

LP3 Network Launches Comprehensive eLearning Program for the Hormonal Health Practitioner

10-Jan-2019 10:30 AM
AVENTURA, Fla.--(BUSINESS WIRE)--Considering the fundamental value for further education on hormonal health, LP3 Network is excited to announce its new partnership with the Institute for Hormonal Health™ (IHH) as the exclusive global distribu

Business Wire Australia and New Zealand

FotoFinder Systems: Artificial Intelligence Revolutionizes Skin Cancer Detection

10-Jan-2019 10:14 AM
Harmless birthmark or dangerous melanoma? Deep learning supports dermatologists   Artificial Intelligence in skin cancer detection (Copyright tiler84, iStock) BAD BIRNBACH, Germany--(BUSINESS WIRE)--"Artificial Intelligence" (

Business Wire Australia and New Zealand

LEO Pharma Strengthens Focus on Translational Medicine with the Appointment of Adam B. Raff, M.D., Ph.D., as Director and Medical Advisor

10-Jan-2019 9:00 AM
  BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma, a global leader in medical dermatology, today announced that Adam B. Raff has been appointed as Director and Medical Advisor in Translational Medicine as of January 28, 2019. Adam Ra

Business Wire Australia and New Zealand

Endovascular Simulation Specialist Mentice Appoints Chief Clinical Officer

10-Jan-2019 8:51 AM
GOTHENBURG, Sweden--(BUSINESS WIRE)--Mentice, the world leading provider of endovascular performance solutions, today announced the appointment of Dr. David J. Ballard as Chief Clinical Officer and Executive Vice President of the Mentice Gr

Business Wire Australia and New Zealand

JPND Launches €30 Million Call for Multinational Research on Personalised Medicine for Neurodegenerative Diseases

09-Jan-2019 6:30 PM
The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative has announced a joint transnational call for multinational research on personalised medicine for neurodegenerative diseases. PARIS--(BUSINESS WIRE

Business Wire Australia and New Zealand

Cambridge Epigenetix announces programme for routine screening and detection of colorectal cancer and other common tumours

09-Jan-2019 9:01 AM
Company granted broad and exclusive patent rights for the use of an epigenetic biomarker as a diagnostic tool for cancer. 5-hydroxymethylcytosine (5hmC) epigenetic sequencing technology platform being used to develop a screening test for

Business Wire Australia and New Zealand

AVITA Medical Announces U.S. National Market Launch of RECELL® System

08-Jan-2019 3:26 PM
Strong market response to the RECELL System approval in advance of U.S. launch with 36 burn centers actively reviewing the product or placing commercial orders VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medic

Business Wire Australia and New Zealand

Takeda Completes Acquisition of Shire, Becoming a Global, Values-Based, R&D-Driven Biopharmaceutical Leader

08-Jan-2019 12:04 PM
8 months from deal announcement to deal close Strong shareholder support with high approval rates on Takeda (89.1%) and Shire (99.8%) Integration planning well underway OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical

Business Wire Australia and New Zealand

Factory CRO and Boston Biomedical Associates Announce Merger

08-Jan-2019 9:32 AM
The merger realizes the shared strategic goal of becoming the leading Global Medical Device and Medical Technology Focused CRO BILTHOVEN, Netherlands & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Factory-CRO Group, a leading global contract

Business Wire Australia and New Zealand

Solasia Initiates Phase III Program for PledOx® in Japan

07-Jan-2019 1:09 PM
TOKYO--(BUSINESS WIRE)--Solasia Pharma K.K. (TOKYO:4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) announced the initiation of Phase III clinical trial for PledOx® in Japan.   In Novemb